We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
631
Increased
3,220
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGU icon
3726
Star Group
SGU
$415M
$26K ﹤0.01%
3,200
+662
+26% +$6.2K
SOND
3727
DELISTED
Sonder
SOND
$26K ﹤0.01%
791
+517
+189% +$17.2K
TARS icon
3728
Tarsus Pharmaceuticals
TARS
$3.04B
$26K ﹤0.01%
1,490
-1,141
-43% -$18.1K
TRC icon
3729
Tejon Ranch
TRC
$442M
$26K ﹤0.01%
1,785
+924
+107% +$14.7K
VSEC icon
3730
VSE Corp
VSEC
$6.79B
$26K ﹤0.01%
735
+68
+10% +$2.64K
PAMT
3731
PAMT Corp
PAMT
$267M
$26K ﹤0.01%
840
+335
+66% +$10.6K
VBFC
3732
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$26K ﹤0.01%
595
-1,311
-69% -$64.6K
BMTX
3733
DELISTED
BM Technologies, Inc.
BMTX
$26K ﹤0.01%
3,876
+2,898
+296% +$17.8K
PSTX
3734
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$26K ﹤0.01%
7,456
-512
-6% -$1.69K
THRX
3735
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$26K ﹤0.01%
4,420
+1,757
+66% +$12.4K
GDNR
3736
DELISTED
Gardiner Healthcare Acquisitions Corp. Common Stock
GDNR
$26K ﹤0.01%
2,619
+101
+4% +$1.01K
CIR
3737
DELISTED
CIRCOR International, Inc
CIR
$26K ﹤0.01%
1,611
+733
+83% +$12.2K
INFI
3738
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$26K ﹤0.01%
22,076
+4,839
+28% +$5.22K
AIP icon
3739
Arteris
AIP
$1.39B
$25K ﹤0.01%
3,742
+1,883
+101% +$14.5K
ALKT icon
3740
Alkami Technology
ALKT
$2.21B
$25K ﹤0.01%
1,648
+43
+3% +$626
ALOT icon
3741
AstroNova
ALOT
$227M
$25K ﹤0.01%
2,136
+1,186
+125% +$14.4K
AMAL icon
3742
Amalgamated Financial
AMAL
$1.53B
$25K ﹤0.01%
1,100
+540
+96% +$12.1K
ATRO icon
3743
Astronics
ATRO
$4.61B
$25K ﹤0.01%
3,859
+734
+23% +$6.12K
BBDC icon
3744
Barings BDC
BBDC
$975M
$25K ﹤0.01%
3,057
-3,181
-51% -$30.7K
BWXT icon
3745
BWX Technologies
BWXT
$15.9B
$25K ﹤0.01%
494
+25
+5% +$1.35K
CRD.B icon
3746
Crawford & Co Class B
CRD.B
$593M
$25K ﹤0.01%
4,805
+3,180
+196% +$20K
CYD icon
3747
China Yuchai International
CYD
$1.7B
$25K ﹤0.01%
3,397
+2,534
+294% +$21.2K
DARE icon
3748
Dare Bioscience
DARE
$13.9M
$25K ﹤0.01%
2,079
+25
+1% +$343
DLTH icon
3749
Duluth Holdings
DLTH
$153M
$25K ﹤0.01%
3,566
-5,083
-59% -$45.4K
DOX icon
3750
Amdocs
DOX
$6.18B
$25K ﹤0.01%
320
-1,127
-78% -$95.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 631 new positions and adding to 3,220 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 631 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.